
Kintur Sanghvi MD FACC FSCAI
Adult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
President, NJ Heart & Vascular Care Princeton / Hamilton, NJ
Join to View Full Profile
6500 K Johnson Blvd# 100CBordentown, NJ 08505
Phone+1 609-759-9660
Fax+1 609-759-9661
Dr. Sanghvi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Named top doctor by "Philadelphia" and "South Jersey Magazine", Kintur A Sanghvi MD, FACC, FSCAI is President at NJ Heart & Vascular Care. He is Professor of Clinical Medicine at Philadelphia College of Osteopathic Medicine.
Dr. Kintur Sanghvi has been intensely focused in learning, researching and teaching cardiovascular medicine since age 23. After practicing in a legendary academic teaching hospital, Deborah Heart & Lung Center, for 11 years, having experience of over 10,000 cardiovascular procedures, publishing multiple research articles, book chapters, and training over 100 cardiologists, he has started NJ Heart & Vascular Care to provide what is missing: A personalized, compassionate and comprehensive care in all the areas of Cardiology, Interventional Cardiology and Endovascular Medicine, including treatment for peripheral vascular disease, structural heart conditions, and venous diseases.
He has been internationally acclaimed and has given talks as a guest faculty in multiple countries across 5 continents. He is one of the pioneers for the wrist artery and foot artery approach for catheterizations. With deep interest in problem solving, he has innovated and published multiple new procedures, techniques, device solutions, and owns multiple patents. He started transradial program, transpedal program, Coronary CTO, TAVR program and Renal Denervation/Hypertension research program at Deborah Heart & Lung Center, which all have became state of the art clinical programs.
Here at NJ Heart & Vascular Care, our Motto: “It is truly a privilege to provide cutting edge, evidence based, comprehensive cardiovascular care to each patient, one at a time."
Special Interest: Sympathetic nervous system modulation/ renal denervation for treatment beyond HTN, trans-pedal approach, Transradial catheterization, Complex coronary and Endovascular interventions, CTO revascularization, Transcatheter Aortic Valve Replacement, PFO closure, ASD Closure.
Education & Training
Corewell Health William Beaumont University HospitalFellowship, Interventional Cardiology, 2008 - 2009
New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Cardiovascular Disease, 2005 - 2008
Jamaica Hospital Medical CenterResidency, Internal Medicine, 2001 - 2004
Pramukhswami Medical CollegeClass of 1996
Certifications & Licensure
NJ State Medical License 2010 - 2027
PA State Medical License 2009 - 2022
MI State Medical License 2008 - 2012
NY State Medical License 2004 - 2009
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- FSCAI Society of Cardiovascular Angiography & Intervention
- Top Docotors South Jersey Magazine, 2018-2019
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013, 2015-2017
Clinical Trials
- Renal Sympathectomy in Treatment Resistant Essential Hypertension, a Sham Controlled Randomized Trial Start of enrollment: 2011 Sep 01
- Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy Start of enrollment: 2016 Feb 05
- A Study of the ReCor Medical Paradise System in Clinical Hypertension
Publications & Presentations
PubMed
- 21 citationsPatient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program.Michel Azizi, Andrew S P Sharp, Naomi D L Fisher, Michael A Weber, Melvin D Lobo
Circulation. 2024-03-05 - 60 citationsPatient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials.Ajay J Kirtane, Andrew S P Sharp, Felix Mahfoud, Naomi D L Fisher, Roland E Schmieder
JAMA Cardiology. 2023-05-01 - 131 citationsEndovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.Michel Azizi, Manish Saxena, Yale Wang, J Stephen Jenkins, Chandan Devireddy
JAMA. 2023-02-28
Journal Articles
- Images in Intervention Intervention of Prohibitive Aortic and Iliac Atherosclerotic Stenosis to Allow Successful Transfemoral Transcatheter Aortic Valve ReplacementKintur Sanghvi, Manjeet Singh, ScienceDirect
- Images in Intervention Prophylactic Ipsilateral Superficial Femoral Artery Access in Patients with Elevated Risk for Femoral Access Complications During Transfemoral T...Kintur Sanghvi, Nicholas Ierovante, ScienceDirect
Press Mentions
Concerto in the Cath Lab Music Benefits Heart Health After PCIOctober 25th, 2025
Cordis Railway Sheathless Access System Minimizes the Radial Artery Trauma: Dr Kintur SanghviFebruary 10th, 2020
Deborah Heart and Lung Center : Kintur Sanghvi, MD, Presents at AimRADIAL & PCI ConferenceNovember 30th, 2018
Research History
- Primary InvestigatorRenal Denervation Trials: RADIANCE II (PI) study of the ReCor Medical Paradise System to evaluate Renal Denervation in Clinical Hypertension RADIANCE HTN (PI) study of the ReCor Medical Paradise System to evaluate Renal Denervation in Clinical Hypertension2015 - Present
Professional Memberships
- Member
- Society For Cardiovascular Angiography & InterventionsFellow
- Member
Other Languages
- Hindi, Gujarati
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









